Background
HIV care in low and middle income countries
Methods
Results
The science of quality improvement in healthcare
HIV-specific QI measurement in resource-limited countries
STEP ALONG CONTINUUM | INDICATORS | ||
---|---|---|---|
UNAIDS | Global Fund for HIV, TB, & Malaria | PEPFAR | |
a) HIV Testing & Diagnosis
| % high risk persons HIV- tested with known result last 12 months | % high risk persons HIV-tested with known result last 12 months | # persons HIV-tested & received result |
% M & F 15-49y HIV tested with known result last 12 months | % M & F 15-49y HIV-tested with known result last 12 months | % M & F 15-49y HIV-tested with known result last 12 months | |
% sexually active M & F 15-24y HIV-tested with known result last 12 months | |||
b) Linkage to Care
| |||
c) ART Eligibility: Clinical, Laboratory, & Psychosocial Assessment↕
| % patients with incident TB treated for TB & HIV | % patients screened for TB | |
% patients that started TB treatment | |||
# malnourished patients that received therapeutic or supplementary food | |||
# eligible clients that received food &/or nutrition services | |||
d) ART Preparation: Literacy Training, OI Prophylaxis, and Adherence Assessment↕
| % eligible adults & children that received co-trimoxazole prophylaxis | # patients that received co-trimoxazole prophylaxis | |
e) ART Initiation
| % adults & children with advanced HIV receiving ART | % adults & children with advanced HIV receiving ART | % adults & children with advanced HIV receiving ART |
% ART facilities monitoring CD4 in accordance with national guidelines | # adults and children with HIV infection newly enrolled on ART | ||
# and% persons starting ART who picked up all ART drugs on time | # adults and children with advanced HIV infection receiving ART | ||
% ART facilities that have experienced a stock-out of at least one required ART drug in the last 12 months | |||
f) Retention in Care
| % adults & children known to be on treatment 12 months after ART initiation | % of adults & children known to be alive & on treatment 12 months after ART initiation | |
Clinical Outcomes
| |||
Other
| % health facilities that offer ART | # service outlets providing ART services according to national or international standards | |
# health workers trained to deliver ART services according to published standards |
The continuum of HIV care as a framework for developing quality improvement measures
a. HIV testing and diagnosis
b. linkage to care
c. Antiretroviral therapy eligibility
d. Antiretroviral therapy – preparation and initiation
e. Retention in care
f. Clinical outcomes
g. Patient-reported outcomes: health-related quality of life and patient satisfaction
Proposed quality measures for HIV programs in resource-limited countries
STEP ALONG CONTINUUM | MEASURE |
---|---|
a) HIV Testing and Diagnosis
| ▪% of patients diagnosed on site [P]
|
▪% of patients diagnosed in other medical facilities [P]
| |
▪% of patients diagnosed via home-based test [P]
| |
▪% of patients diagnosed in mobile testing unit [P]
| |
▪% of couples whose partners have been HIV tested and are aware of results [P]
| |
b) Linkage to Care
| ▪ Median days from HIV diagnosis to referral for ART or pre-ART care [P]
|
▪% of patients ART ineligible at baseline who receive a follow-up CD4 count in 6 months [P]
| |
▪ Median days from clinic enrollment to ART eligibility [P]
| |
▪% of patients who are enrolled in HIV clinic, received CD4 count & results within 3 months of HIV diagnosis [P]
| |
▪% of patients with CD4 count ≤ 200 cells/uL, & ≤ 350 cells/uL at presentation [P]
| |
c) ART Eligibility: Clinical, Laboratory & Psychosocial Assessment
| ▪% of patients screened for tuberculosis [P]
|
▪% of eligible patients provided with nutritional supplementation [P]
| |
▪% of ART-eligible patients who died before ART initiation [O]
| |
d) ART Preparation: Literacy Training, OI Prophylaxis, and Adherence Assessment
| ▪ Median days from enrollment to ART initiation for eligible patients [P]
|
▪ Median days from enrollment to completion of ART literacy training for eligible patients [P]
| |
e) ART Initiation
| ▪ # drug stock outs in last quarter for first-line ART drugs or cotrimoxazole [P]
|
▪ Local guideline concordance (e.g. CD4 testing, adherence monitoring, assessment for drug toxicity, OI screening & prophylaxis) [P]
| |
f) Retention in Care
| ▪% of patients retained in care 6 and 12 months from enrollment (ART eligible and ART-ineligible) [O]
|
▪% of patients who transferred care to other clinics 6 and 12 months from enrollment [O]
| |
▪% of patients deemed lost to follow-up who have been contacted by clinic staff to determine outcome [O]
| |
g) Clinical Outcomes
| ▪% of patients on ART with undetectable viral load at 12 months [O]
|
▪% of patients on ART requiring switch to second-line therapy for treatment failure at 12 and 24 months [O]
| |
▪% of patients (ART-eligible on and off ART) who died 12 months after enrollment [O]
| |
h) Patient Reported Outcomes
| ▪ patient-reported health status 6 and 12 months after clinic enrollment [O]
|